SARS-CoV-2 and Research Funding: Do No Harm
- PMID: 32463718
- DOI: 10.1089/hs.2020.0053
SARS-CoV-2 and Research Funding: Do No Harm
Similar articles
-
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097. JAMA. 2020. PMID: 31999307 No abstract available.
-
Travel restrictions in the rising COVID-19 pandemic.Hong Kong Med J. 2020 Jun;26(3):255-257. doi: 10.12809/hkmj208554. Epub 2020 Jun 3. Hong Kong Med J. 2020. PMID: 32487773 No abstract available.
-
Travel restrictions hampering COVID-19 response.Lancet. 2020 Apr 25;395(10233):1331-1332. doi: 10.1016/S0140-6736(20)30967-3. Lancet. 2020. PMID: 32334692 Free PMC article. No abstract available.
-
Time to strengthen capacity in infectious disease control at the European level.Int J Infect Dis. 2020 Oct;99:263-265. doi: 10.1016/j.ijid.2020.08.005. Epub 2020 Aug 8. Int J Infect Dis. 2020. PMID: 32781163 Free PMC article. Review.
-
BCG as an adjunct or alternative vaccine to prevent COVID-19?J Travel Med. 2020 Nov 9;27(7):taaa175. doi: 10.1093/jtm/taaa175. J Travel Med. 2020. PMID: 33073845 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous